Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Lipoprotein(a) Is the Best Single Marker in Assessing Unstable Angina Pectoris.

Djordjević VB, Cosić V, Stojanović I, Kundalić S, Zvezdanović L, Deljanin-Ilić M, Vlahović P, Popović L.

Cardiol Res Pract. 2011 Mar 7;2011:175363. doi: 10.4061/2011/175363.

2.
3.

Serum Fas/FasL levels in dependence on clinical presentations of coronary disease and their relationship with risk factors.

Ristić T, Djordjević VB, Deljanin-Ilić M, Cosić V, Kundalić S.

Vojnosanit Pregl. 2010 Jul;67(7):537-42.

PMID:
20707047
4.

High clinical accuracy of asymmetric dimethylarginine and symmetric dimethylarginine in patients with ischemic heart disease.

Djordjević BV, Pavlović R, Ćosić V, Deljanin-Ilić M, Ristić T, Krstić N, Jevtović-Stoimenov T.

Amino Acids. 2012 Dec;43(6):2293-300. doi: 10.1007/s00726-012-1307-x. Epub 2012 May 4.

PMID:
22555650
5.

API expert consensus document on management of ischemic heart disease.

Association of Physicians of India.

J Assoc Physicians India. 2006 Jun;54:469-80. Review.

PMID:
16909697
6.

Oxidized low-density lipoprotein cholesterol and the ratio in the diagnosis and evaluation of therapeutic effect in patients with coronary artery disease.

Huang H, Ma R, Liu D, Liu C, Ma Y, Mai W, Dong Y.

Dis Markers. 2012;33(6):295-302. doi: 10.3233/DMA-2012-00941.

7.

Variability in lipid profile among patients presented with acute myocardial infarction, unstable angina and stable angina pectoris.

Yang N, Feng JP, Chen G, Kou L, Li Y, Ren P, Zhao LL, Qin Q.

Eur Rev Med Pharmacol Sci. 2014;18(24):3761-6.

8.
9.

The oxidation ratio of LDL: a predictor for coronary artery disease.

Huang H, Mai W, Liu D, Hao Y, Tao J, Dong Y.

Dis Markers. 2008;24(6):341-9.

10.

Association between statin treatment and LDL-cholesterol levels on the rate of ST-elevation myocardial infarction among patients with acute coronary syndromes: ACS Israeli Survey (ACSIS) 2002-2010.

Gottlieb S, Kolker S, Shlomo N, Matetzky S, Leitersdorf E, Segev A, Goldenberg I, Tzivoni D, Weisz G, Moriel M.

Int J Cardiol. 2016 May 1;210:133-8. doi: 10.1016/j.ijcard.2016.02.088. Epub 2016 Feb 18.

PMID:
26945433
11.

Comparison of outcomes after percutaneous coronary intervention among different coronary subsets (stable and unstable angina pectoris and ST-segment and non-ST-segment myocardial infarction).

Loh JP, Pendyala LK, Kitabata H, Torguson R, Omar A, Minha S, Chen F, Satler LF, Pichard AD, Waksman R.

Am J Cardiol. 2014 Jun 1;113(11):1794-801. doi: 10.1016/j.amjcard.2014.03.007. Epub 2014 Mar 15.

PMID:
24837256
12.

Congestive heart failure is associated with lipoprotein components in statin-treated patients with coronary heart disease Insights from the Incremental Decrease in End points Through Aggressive Lipid Lowering Trial (IDEAL).

Holme I, Strandberg TE, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Larsen ML, Lindahl C, Pedersen TR; Incremental Decrease in End Points Through Aggressive Lipid Lowering Study Group.

Atherosclerosis. 2009 Aug;205(2):522-7. doi: 10.1016/j.atherosclerosis.2009.01.023. Epub 2009 Jan 24.

PMID:
19327776
13.

Comparative effects of high-dose atorvastatin versus moderate-dose rosuvastatin on lipid parameters, oxidized-LDL and inflammatory markers in ST elevation myocardial infarction.

Aydin MU, Aygul N, Altunkeser BB, Unlu A, Taner A.

Atherosclerosis. 2015 Apr;239(2):439-43. doi: 10.1016/j.atherosclerosis.2015.02.003. Epub 2015 Feb 7.

PMID:
25697576
14.

Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis.

Boekholdt SM, Arsenault BJ, Mora S, Pedersen TR, LaRosa JC, Nestel PJ, Simes RJ, Durrington P, Hitman GA, Welch KM, DeMicco DA, Zwinderman AH, Clearfield MB, Downs JR, Tonkin AM, Colhoun HM, Gotto AM Jr, Ridker PM, Kastelein JJ.

JAMA. 2012 Mar 28;307(12):1302-9. doi: 10.1001/jama.2012.366. Erratum in: JAMA. 2012 May 9;307(18):1915. JAMA. 2012 Apr 25;307(16):1694.

PMID:
22453571
15.

Comparative diagnostic accuracy of serum levels of neutrophil activating peptide-2 and pentraxin-3 versus troponin-I in acute coronary syndrome.

Ustündağ M, Orak M, Güloğlu C, Sayhan MB, Alyan O, Kale E.

Anadolu Kardiyol Derg. 2011 Nov;11(7):588-94. doi: 10.5152/akd.2011.160. Epub 2011 Sep 12.

16.

Plasma vaspin concentrations are decreased in acute coronary syndrome, but unchanged in patients without coronary lesions.

Zhang B, Peng W, Li H, Lu Y, Zhuang J, Wang K, Su Y, Xu Y.

Clin Biochem. 2013 Oct;46(15):1520-5. doi: 10.1016/j.clinbiochem.2013.06.028. Epub 2013 Jul 11.

PMID:
23850850
17.

Relationship Between MMP-1, MMP-9, TIMP-1, IL-6 and Risk Factors, Clinical Presentation, Extent and Severity of Atherosclerotic Coronary Artery Disease.

Tanindi A, Sahinarslan A, Elbeg S, Cemri M.

Open Cardiovasc Med J. 2011;5:110-6. doi: 10.2174/1874192401105010110. Epub 2011 May 13.

18.
19.
20.

Lipoprotein (a) is increased in acute coronary syndromes (unstable angina pectoris and myocardial infarction), but it is not predictive of the severity of coronary lesions.

Brunelli C, Spallarossa P, Bertolini S, Balbi M, Barbara C, Masturzo P, Lantieri PB, Pastorini C, Caponnetto S.

Clin Cardiol. 1995 Sep;18(9):526-9.

Supplemental Content

Support Center